Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Tchen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|December 4, 1998
[Interferon alpha in the treatment of non-Hodgkin's lymphomas of low malignancy]A Monnereau, P Soubeyran, F Bonichon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Semen analysis and cryoconservation before treatment in Hodgkin's diseaseFitoussi, H Eghbali, N Tchen, et al.
Lancet (London, England)|October 8, 1999
Taxane-induced glaucomaE Fabre-Guillevin, N Tchen, M F Anibali-Charpiat, et al.
Critical Reviews in Oncology/Hematology|June 23, 2000
Current treatment of Hodgkin's diseaseH Eghbali, P Soubeyran, N Tchen, et al.
Critical Reviews in Oncology/Hematology|June 23, 2000
Follicular lymphomas--a review of treatment modalitiesP Soubeyran, M Debled, N Tchen, et al.
British Journal of Cancer|August 14, 2003
Quality of life and understanding of disease status among cancer patients of different ethnic originN Tchen, P Bedard, Q-L Yi, et al.
Bulletin Du Cancer|July 1, 1997
[Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases]N Tchen, H Eghbali, P Soubeyran, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|December 4, 1998
[Interferon alpha in the treatment of non-Hodgkin's lymphomas of low malignancy]A Monnereau, P Soubeyran, F Bonichon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Semen analysis and cryoconservation before treatment in Hodgkin's diseaseFitoussi, H Eghbali, N Tchen, et al.
Lancet (London, England)|October 8, 1999
Taxane-induced glaucomaE Fabre-Guillevin, N Tchen, M F Anibali-Charpiat, et al.
Critical Reviews in Oncology/Hematology|June 23, 2000
Current treatment of Hodgkin's diseaseH Eghbali, P Soubeyran, N Tchen, et al.
Critical Reviews in Oncology/Hematology|June 23, 2000
Follicular lymphomas--a review of treatment modalitiesP Soubeyran, M Debled, N Tchen, et al.
British Journal of Cancer|August 14, 2003
Quality of life and understanding of disease status among cancer patients of different ethnic originN Tchen, P Bedard, Q-L Yi, et al.
Bulletin Du Cancer|July 1, 1997
[Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases]N Tchen, H Eghbali, P Soubeyran, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
Pageof 1